Testing that earns its place
Our core panel focuses on the markers with the strongest outcome evidence: apolipoprotein B (ApoB), lipoprotein(a), the full lipid profile, HbA1c, fasting glucose, and supporting metabolic and renal markers. These are the measurements that guidelines and outcome studies actually support for prevention in adults.
We deliberately exclude unvalidated novelty tests from standard panels. Where an exploratory test has value – and we label it clearly as exploratory – it is offered as an option, never as theatre.
From panel to interpretation
A number without context is noise. The physician reads every result together with your medical history, medications, family history, examination findings and wearable data. Reference intervals are general; your context is specific. The difference between the two is where medical judgement lives.
Every assessment concludes with a written health report: what was measured, what it means, what is stable and what deserves attention – in language you can act on and share with your own physicians.
Trends, not snapshots
Single values are weak evidence. In our longitudinal programs, biomarkers are re-assessed periodically under comparable conditions and compared against your baseline and your historical results. Records you supply from previous laboratories can be incorporated, subject to available formats and clinical verification – so your history becomes part of the analysis rather than a footnote.
NQ PRECISION delivers a complete baseline assessment; NQ CONTINUOUS and NQ PRIVATE continue the monitoring over years, with periodic reassessment built into the program.
